DAVIS TODD C received a stock award from LIGAND PHARMACEUTICALS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/19/2025ACC: 0002001011-25-000013
+7.33K
Net shares
Net buyer
$1.61M
Total sold
0
Open market trades
0B · 0S
4
Total transactions
20.78K acquired · 13.45K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+20.78K
Price / share
—
Trade value
—
% of position
16.9%
2/14/2025
123.01K→143.79K
Common Stock
Direct
Shares
−6.97K
Price / share
$120.00
Trade value
$835.92K
% of position
4.8%
2/14/2025
143.79K→136.83K
Common Stock
Direct
Shares
−2.23K
Price / share
$120.00
Trade value
$267.72K
% of position
1.6%
2/15/2025
136.83K→134.60K
Common Stock
Direct
Shares
−4.25K
Price / share
$120.00
Trade value
$510.60K
% of position
3.2%
2/15/2025
134.60K→130.34K
Total
Net shares
+7.33K
Net value
-$1.61M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/14/2025 | A · Award | +20.78K | — | — | 16.9% | 123.01K | 143.79K |
| Common Stock Direct | 2/14/2025 | F · Tax Withholding | −6.97K | $120.00 | $835.92K | 4.8% | 143.79K | 136.83K |
| Common Stock Direct | 2/15/2025 | F · Tax Withholding | −2.23K | $120.00 | $267.72K | 1.6% | 136.83K | 134.60K |
| Common Stock Direct | 2/15/2025 | F · Tax Withholding | −4.25K | $120.00 | $510.60K | 3.2% | 134.60K | 130.34K |
| Total | +7.33K | -$1.61M | ||||||
Derivative Transactions0
No derivative transactions reported